SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039925
Filing Date
2022-02-14
Accepted
2022-02-14 09:18:51
Documents
2
Group Members
NAN FUNG GROUP HOLDINGS LTDNAN FUNG LIFE SCIENCES HOLDINGS LTDNF INVESTMENT HOLDINGS LTDNFLS BETA LTDNFLS PLATFORM HOLDINGS LTDPIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.PIVOTAL LIFE SCIENCES LTDPIVOTAL PAR

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d237570dsc13ga.htm SC 13G/A 156592
2 EXHIBIT 1 d237570dex991.htm EX-99.1 12948
  Complete submission text file 0001193125-22-039925.txt   171548
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-410-1818
Akouos, Inc. (Subject) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91555 | Film No.: 22626092
SIC: 2834 Pharmaceutical Preparations